Analysis of Associations of Human BAFF gene polymorphisms with autoimmune thyroid diseases

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Lin, Jiunn Diann ^a,b   Yang, Shun Fa ^c,d   Wang, Yuan Hung ^a,b   Fang, Wen Fang ^b   Lin, Ying Chin ^b   Lin, Yuh Feng ^a,b   Tang, Kam Tsun ^e   Wu, Mei Yi ^b   Cheng, Chao Wen ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; MICROSOME ANTIBODY; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY; TNFSF13B PROTEIN, HUMAN;

ADULT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE THYROIDITIS; B LYMPHOCYTE ACTIVATING FACTOR GENE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HAPLOTYPE; MIDDLE AGED; THYROID DISEASE;

ADULT; ALLELES; B-CELL ACTIVATING FACTOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAVES DISEASE; HAPLOTYPES; HASHIMOTO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; THYROID DISEASES;

EID: 84966710629     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154436     Document Type: Article

References (41)

1. Yanaba K, Bouaziz JD, Matsushita T, Magro CM, St Clair EW, Tedder TF (2008) B-lymphocyte contributions to human autoimmune disease. Immunol Rev 223: 284-299. doi: 10.1111/j.1600-065X.2008.00646.x PMID: 18613843
2. Thompson JS, Schneider P, Kalled SL, Wang L, Lefevre EA, Cachero TG, et al. (2000) BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J Exp Med 192: 129-135. PMID: 10880534
3. Thien M, Phan TG, Gardam S, Amesbury M, Basten A, Mackay F, et al. (2004) Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20: 785-798. PMID: 15189742
4. Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, et al. (1999) BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285: 260-263. PMID: 10398604
5. Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, et al. (1999) Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190: 1697-1710. PMID: 10587360
6. Zhang J, Roschke V, Baker KP, Wang Z, Alarcon GS, Fessler BJ, et al. (2001) Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 166: 6-10. PMID: 11123269
7. Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T, et al. (2003) The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann Rheum Dis 62: 168-171. PMID: 12525388
8. Migita K, Ilyassova B, Kovzel EF, Nersesov A, Abiru S, Maeda Y, et al. (2010) Serum BAFF and APRIL levels in patients with PBC. Clin Immunol 134: 217-225. doi: 10.1016/j.clim.2009.09.007 PMID: 19840904
9. Cheema GS, Roschke V, Hilbert DM, Stohl W (2001) Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 44: 1313-1319. PMID: 11407690
10. Nossent JC, Lester S, Zahra D, Mackay CR, Rischmueller M (2008) Polymorphism in the 5′ regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome. Rheumatology (Oxford) 47: 1311-1316.
11. Kawasaki A, Tsuchiya N, Fukazawa T, Hashimoto H, Tokunaga K (2002) Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis. Genes Immun 3: 424-429. PMID: 12424625
12. Clark WB, Brown-Gentry KD, Crawford DC, Fan KH, Snavely J, Chen H, et al. (2011) Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD. Blood 118: 1140-1144. doi: 10.1182/blood-2010-09-310011 PMID: 21628416
13. Nezos A, Papageorgiou A, Fragoulis G, Ioakeimidis D, Koutsilieris M, Tzioufas AG, et al. (2014) B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome. J Autoimmun 51: 89-98. doi: 10.1016/j.jaut.2013.04.005 PMID: 23845207
14. Ruyssen-Witrand A, Rouanet S, Combe B, Dougados M, Le Loet X, Sibilia J, et al. (2013) Association between -871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients. Rheumatology (Oxford) 52: 636-641.
15. de Almeida ER, Petzl-Erler ML (2013) Expression of genes involved in susceptibility to multifactorial autoimmune diseases: estimating genotype effects. Int J Immunogenet 40: 178-185. doi: 10.1111/j.1744-313X.2012.01152.x PMID: 22928528
16. Emmerich F, Bal G, Barakat A, Milz J, Muhle C, Martinez-Gamboa L, et al. (2007) High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura. Br J Haematol 136: 309-314. PMID: 17156395
17. Hasham A, Tomer Y (2012) Genetic and epigenetic mechanisms in thyroid autoimmunity. Immunol Res 54: 204-213. doi: 10.1007/s12026-012-8302-x PMID: 22457094
18. Tomer Y, Huber A (2009) The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun 32: 231-239. doi: 10.1016/j.jaut.2009.02.007 PMID: 19307103
19. Gilbert JA, Kalled SL, Moorhead J, Hess DM, Rennert P, Li Z, et al. (2006) Treatment of autoimmune hyperthyroidism in a murine model of Graves' disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathology. Endocrinology 147: 4561-4568. PMID: 16794009
20. Fabris M, Grimaldi F, Villalta D, Picierno A, Fabro C, Bolzan M, et al. (2010) BLyS and April serum levels in patients with autoimmune thyroid diseases. Autoimmun Rev 9: 165-169. doi: 10.1016/j.autrev.2009.07.005 PMID: 19647102
21. Vannucchi G, Covelli D, Curro N, Dazzi D, Maffini A, Campi I, et al. (2012) Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy. J Clin Endocrinol Metab 97: E755-759. doi: 10.1210/jc.2011-2614 PMID: 22399512
22. Sanders J, Oda Y, Roberts S, Kiddie A, Richards T, Bolton J, et al. (1999) The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor. J Clin Endocrinol Metab 84: 3797-3802. PMID: 10523032
23. Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, et al. (2002) Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest 109: 59-68. PMID: 11781351
24. Mavragani CP, Niewold TB, Moutsopoulos NM, Pillemer SR, Wahl SM, Crow MK (2007) Augmented interferon-alpha pathway activation in patients with Sjogren's syndrome treated with etanercept. Arthritis Rheum 56: 3995-4004. PMID: 18050196
25. Lopez P, Scheel-Toellner D, Rodriguez-Carrio J, Caminal-Montero L, Gordon C, Suarez A (2014) Interferon-alpha-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes. Rheumatology (Oxford) 53: 2249-2258.
26. Kannel K, Alnek K, Vahter L, Gross-Paju K, Uibo R, Kisand KV (2015) Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome. PLoS One 10: e0143393. doi: 10.1371/journal.pone.0143393 PMID: 26600308
27. Russo MW, Fried MW (2003) Side effects of therapy for chronic hepatitis C. Gastroenterology 124: 1711-1719. PMID: 12761728
28. Tomer Y (2010) Hepatitis C and interferon induced thyroiditis. J Autoimmun 34: J322-326. doi: 10.1016/j.jaut.2009.11.008 PMID: 20022216
29. Lin JD, Wang YH, Liu CH, Lin YC, Lin JA, Lin YF, et al. (2015) Association of IRF8 gene polymorphisms with autoimmune thyroid disease. Eur J Clin Invest 45: 711-719. doi: 10.1111/eci.12463 PMID: 25989711
30. Kahles H, Ramos-Lopez E, Lange B, Zwermann O, Reincke M, Badenhoop K (2005) Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. Eur J Endocrinol 153: 895-899. PMID: 16322396
31. Liao WL, Chen RH, Lin HJ, Liu YH, Chen WC, Tsai Y, et al. (2010) Toll-like receptor gene polymorphisms are associated with susceptibility to Graves' ophthalmopathy in Taiwan males. BMC Med Genet 11: 154. doi: 10.1186/1471-2350-11-154 PMID: 21050493
32. Ben-Selma W, Ben-Fredj N, Chebel S, Frih-Ayed M, Aouni M, Boukadida J (2015) Age- and gender-specific effects on VDR gene polymorphisms and risk of the development of multiple sclerosis in Tunisians: a preliminary study. Int J Immunogenet 42: 174-181. doi: 10.1111/iji.12197 PMID: 25892553
33. Avidan N, Le Panse R, Berrih-Aknin S, Miller A (2014) Genetic basis of myasthenia gravis - a comprehensive review. J Autoimmun 52: 146-153. doi: 10.1016/j.jaut.2013.12.001 PMID: 24361103
34. Liu LY, Schaub MA, Sirota M, Butte AJ (2012) Sex differences in disease risk from reported genome-wide association study findings. Hum Genet 131: 353-364. doi: 10.1007/s00439-011-1081-y PMID: 21858542
35. Gregersen PK, Kosoy R, Lee AT, Lamb J, Sussman J, McKee D, et al. (2012) Risk for myasthenia gravis maps to a (151) Pro - >Ala change in TNIP1 and to human leukocyte antigen-B∗08. Ann Neurol 72: 927-935. doi: 10.1002/ana.23691 PMID: 23055271
36. Zandman-Goddard G, Peeva E, Shoenfeld Y (2007) Gender and autoimmunity. Autoimmun Rev 6: 366-372. PMID: 17537382
37. Pongratz G, Straub RH, Scholmerich J, Fleck M, Harle P (2010) Serum BAFF strongly correlates with PsA activity in male patients only - is there a role for sex hormones? Clin Exp Rheumatol 28: 813-819. PMID: 20863443
38. Panchanathan R, Choubey D (2013) Murine BAFF expression is up-regulated by estrogen and interferons: implications for sex bias in the development of autoimmunity. Mol Immunol 53: 15-23. doi: 10.1016/j.molimm.2012.06.013 PMID: 22784990
39. Gavin AL, Ait-Azzouzene D, Ware CF, Nemazee D (2003) DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF. J Biol Chem 278: 38220-38228. PMID: 12867412
40. Roescher N, Vosters JL, Alsaleh G, Dreyfus P, Jacques S, Chiocchia G, et al. (2014) Targeting the splicing of mRNA in autoimmune diseases: BAFF inhibition in Sjogren's syndrome as a proof of concept. Mol Ther 22: 821-827. doi: 10.1038/mt.2013.275 PMID: 24304965
41. Hiratani H, Bowden DW, Ikegami S, Shirasawa S, Shimizu A, Iwatani Y, et al. (2005) Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. J Clin Endocrinol Metab 90: 2898-2903. PMID: 15741259